TCDD has been shown to inhibit estradiol-induced cell growth and proliferation as well as other pathways regulated by estrogens, including methylation of CYP1A1, in a variety of human breast cancer cell culture lines [506, 507]. Here, CYP1A1 is linked to breast carcinoma.